Vimentin is widely used to detect mesenchymal-like CTCs in aggressive cancer subtypes such as small cell lung cancer (SCLC), advanced NSCLC, and poorly differentiated pancreatic cancer [92, 93]. This evidence concerns the gene VIM and cancer.